ASTHMA/COPD

12345678910111213141516171819202122232425
Across
  1. 3. Device that helps with proper administration by ensuring medications go directly to the site of action
  2. 6. Mutation of this gene leads to alpha 1 antitrypsin deficiency
  3. 7. Montelukast has a boxed warning for these types of events
  4. 13. Time course of COPD over years despite treatment
  5. 17. Characterized as a peak flow 80-100% of personal best and no symptoms in an asthma action plan
  6. 19. Pathophysiology of COPD includes airflow obstruction and ___
  7. 23. Formoterol onset of action
  8. 24. Rinse and spit after ICS to prevent ___
  9. 25. Heterogenous disease, usually characterized by chronic airway inflammation
Down
  1. 1. Formoterol is a ___
  2. 2. Low dose ICS-formoterol PRN is the ___ reliever
  3. 4. ___ medications contain an ICS in asthma
  4. 5. Ipratropium is a ___
  5. 8. Defined as an acute narrowing of the airways as a result of exercise
  6. 9. Questionnaire assessing health status
  7. 10. The most reproducible and objective measurement of airflow obstruction
  8. 11. Budesonide is an ___
  9. 12. Volume of air exhaled forcefully in the first second to maximal expiration
  10. 14. Clinical guide to initiate pharmacological treatment by assessing symptoms and exacerbation history
  11. 15. ___ medications are provided to all patients for breakthrough symptoms
  12. 16. Questionnaire developed to measure breathlessness
  13. 18. Take medications ___ prior to exercise for prevention
  14. 20. ACOS should be treated as ___
  15. 21. Prevalence of COPD is ___ related to the prevalence of tobacco smoking
  16. 22. Proposed term to illustrate the complex and dynamic series of interactions over time in COPD